Aleman M, Nieto JE, Magdesian KG (2009) Malignant hyperthermia associated with ryanodine
receptor 1 (C7360G) mutation in Quarter Horses. J Vet Intern Med 23:329–334
Bellah JR, Robertson SA, Buergelt CD, McGavin AD (1989) Suspected malignant hyperthermia
after halothane anesthesia in a cat. Vet Surg 18:483–488
Berman MC, Harrison GG, Bull AB, Kench JE (1970) Changes underlying halothane-induced
malignant hyperpyrexia in Landrace pigs. Nature 225:653–655
Blaisdell J, Goldstein JA, Bai SA (1998) Isolation of a new canine cytochrome P450 cDNA from
the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in
its expression. Drug Metab Dispos 26:278–283
Boukouvala S, Price N, Sim E (2002) Identification and functional characterization of novel
polymorphisms associated with the genes for arylamineN-acetyltransferases in mice. Pharma-
cogenetics 12:385–394
Brunson DB, Hogan KJ (2004) Malignant hyperthermia: a syndrome not a disease. Vet Clin North
Am Small Anim Pract 34:1419–1433
Carson PE, Flanagan CL, Ickes CE, Alving AS (1956) Enzymatic deficiency in primaquine-
sensitive erythrocytes. Science 124:484–485
Corser RB, Coughtrie MWH, Jackson MR, Burchell B (1987) The molecular-basis of the
inherited deficiency of androsterone UDP-glucuronyltransferase in Wistar rats. FEBS Lett
213:448–452
Cosgrove SB, Eisele PH, Martucci RW, Gronert GA (1992) Evaluation of greyhound susceptibility
to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane
muscle contractures. Lab Anim Sci 42:482–485
Court MH (1999) Anesthesia of the sighthound. Clin Tech Small Anim Pract 14:38–43
Court MH (2007) A pharmacogenomics primer. J Clin Pharmacol 47:1087–1103
Court MH, Hay-Kraus BL, Hill DW, Kind AJ, Greenblatt DJ (1999) Propofol hydroxylation by
dog liver microsomes: assay development and dog breed differences. Drug Metab Dispos
27:1293–1299
Curtis MB, Eicker SE (1991) Pharmacodynamic properties of succinylcholine in greyhounds. Am
J Vet Res 52:898–902
de Jong RH, Heavner JE, Amory DW (1974) Malignant hyperpyrexia in the cat. Anesthesiology
41:608–609
de Morais SM, Wells PG (1989) Enhanced acetaminophen toxicity in rats with bilirubin glucur-
onyl transferase deficiency. Hepatology 10:163–167
DeLeon JH, Martell KJ, Vatsis KP, Weber WW (1995) Slow acetylation in mice is caused by a
labile and catalytically impaired mutantN-acetyltransferase (NAT2 9). Drug Metab Dispos
23:1354–1361
Dietrich CG, Ottenhoff R, de Waart DR, Elferink R (2001) Lack of UGT1 isoforms in Gunn rats
changes metabolic ratio and facilitates excretion of the food-derived carcinogen 2-amino-1-
methyl-6-phenylimidazo[4, 5-b]pyridine. Toxicol Appl Pharmacol 170:137–143
Fakis G, Boukouvala S, Kawamura A, Kennedy S (2007) Description of a novel polymorphic gene
encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model
animal for endometriosis. Pharmacogenet Genomics 17:181–188
Ferguson RJ, Doll MA, Rustan TD, Hein DW (1996) Cloning, expression, and functional
characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding
genes of the Syrian hamster. Pharmacogenetics 6:55–66
Foster AP, Shaw SE, Duley JA, Shobowale-Bakre EM, Harbour DA (2000) Demonstration
of thiopurine methyltransferase activity in the erythrocytes of cats. J Vet Intern Med
14:552–554
Frymoyer JW, Jacox RF (1963) Studies of genetically controlled sulfadiazine acetylation in rabbit
livers: possible identification of the heterozygous trait. J Lab Clin Med 62:905–909
Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VK, Weiler JE, O’Brien PJ, MacLennan DH (1991)
Identification of a mutation in porcine ryanodine receptor associated with malignant hyper-
thermia. Science 253:448–451
Comparative and Veterinary Pharmacogenomics 71